ARDX
Ardelyx, Inc. · Healthcare
Chief Development Officer David P. Rosenbaum sold $39K of Ardelyx, Inc.
Sold$38,850
$5.55Price
7,000Shares
−1%Stake
What ARDX did after the filing
- The stock from Fri, Dec 15 close, $5.91
- +47.7%
- S&P 500, same days
- +2.9%
Measured over 30 trading days, to the Jan 31 close.
Traded Thu, Dec 14. Filed Fri, Dec 15, 1:13 PM ET, during the session. Returns use the Dec 15 close and the Jan 31 close. Not investment advice.